Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 11577 [2017-03647]
Download as PDF
<![CDATA[
11577
Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices
in early intervention services before six
months of age for those identified with
hearing loss.
Federal support for identifying
children with hearing loss began with
the Children’s Health Act of 2000,
which authorized federal programs to
support EHDI activities at the state
level. Since then, funds have been
distributed to states via cooperative
agreements from the CDC and grants
from the Health Resources and Services
Administration (HRSA). States are using
these federal monies to enhance EHDI
programs and develop corresponding
tracking and surveillance systems.
These systems are intended to help
EHDI programs ensure infants and
children are receiving recommended
hearing screening, follow-up, and
intervention services.
The mission of the CDC EHDI team is
for every state and U.S. territory to have
a complete EHDI tracking and
surveillance system that will help
ensure infants and children with
hearing loss achieve communication
and social skills commensurate with
their cognitive abilities. As part of this
mission the CDC EHDI team, in
collaboration with representatives of
state and U.S. territorial EHDI programs,
developed seven National EHDI Goals
that reflect the ‘‘1–3–6 plan’’ and
address integration with the medical
home (coordinated care by a medical
provider) and development of tracking
and surveillance systems to minimize
loss to follow-up and loss to
documentation. Many of the defined
performance indicators for these goals
involve obtaining data related to the
number of children screened for hearing
loss, referred for and receiving followup testing (e.g., diagnostic audiologic
evaluation) and enrolled in early
intervention services.
The purpose of the revised survey is
to obtain annual state data on the
performance indicators in a consistent
manner, which is needed to assess
progress towards meeting the National
EHDI goals. In addition, the availability
of these data will better enable the CDC
EHDI team to provide technical
assistance to states and respond to
questions by the general public, policy
makers, and Healthy People 2020
officials.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
EHDI Program State Program Coordinators Contacted .........
EHDI Program State Program Coordinators who return the
survey.
Survey Directions ...................
Survey ....................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–03593 Filed 2–23–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcements
(FOAs): CK17–001, ‘‘Creation of a
Healthcare-Associated Infectious
Disease Modeling Network to Improve
Prevention Research and Healthcare
Delivery’’; CK17–002, ‘‘Evaluation of
Clinical Interventions, Surveillance, and
Ecological Factors that Influence the
Burden of Human Monkeypox in the
Democratic Republic of the Congo
(DRC)’’; and CK17–004, ‘‘Determining
VerDate Sep<11>2014
17:20 Feb 23, 2017
Jkt 241001
and Monitoring Health Conditions
Identified in the Medical Assessment of
US-Bound Refugees.’’
Time and Date:
10:00 a.m.–5:00 p.m., EDT, March 28–
29, 2017 (Closed)
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Creation of a Healthcare-Associated
Infectious Disease Modeling Network to
Improve Prevention Research and
Healthcare Delivery’’, CK17–001;
‘‘Evaluation of Clinical Interventions,
Surveillance, and Ecological Factors
that Influence the Burden of Human
Monkeypox in the Democratic Republic
of the Congo (DRC)’’, CK17–002; and
‘‘Determining and Monitoring Health
Conditions Identified in the Medical
Assessment of US-Bound Refugees’’,
CK17–004.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
59
57
Average
burden per
response
(in hours)
1
1
10/60
240/60
Georgia 30333, Telephone: (404) 718–
8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–03647 Filed 2–23–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
ICD–10 Coordination and Maintenance
(C&M) Committee Meeting National
Center for Health Statistics (NCHS),
Classifications and Public Health Data
Standards Staff, Announces the
Following Meeting
ICD–10 Coordination and
Maintenance (C&M) Committee meeting.
TIME AND DATE: 9:00 a.m.–5:00 p.m.,
EST, March 7–8, 2017
NAME:
E:\FR\FM\24FEN1.SGM
24FEN1
]]>Agencies
[Federal Register Volume 82, Number 36 (Friday, February 24, 2017)]
[Notices]
[Page 11577]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03647]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Funding Opportunity Announcements (FOAs):
CK17-001, ``Creation of a Healthcare-Associated Infectious Disease
Modeling Network to Improve Prevention Research and Healthcare
Delivery''; CK17-002, ``Evaluation of Clinical Interventions,
Surveillance, and Ecological Factors that Influence the Burden of Human
Monkeypox in the Democratic Republic of the Congo (DRC)''; and CK17-
004, ``Determining and Monitoring Health Conditions Identified in the
Medical Assessment of US-Bound Refugees.''
Time and Date:
10:00 a.m.-5:00 p.m., EDT, March 28-29, 2017 (Closed)
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and
the determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Creation of a Healthcare-Associated Infectious Disease Modeling
Network to Improve Prevention Research and Healthcare Delivery'', CK17-
001; ``Evaluation of Clinical Interventions, Surveillance, and
Ecological Factors that Influence the Burden of Human Monkeypox in the
Democratic Republic of the Congo (DRC)'', CK17-002; and ``Determining
and Monitoring Health Conditions Identified in the Medical Assessment
of US-Bound Refugees'', CK17-004.
Contact Person for More Information: Gregory Anderson, M.S.,
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop
E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-03647 Filed 2-23-17; 8:45 am]
BILLING CODE 4163-18-P
